Showing results (771-780 of 826) with videos related to

Sort By:
Pageof 83
British Journal of Cancer|May 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsGiovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, et al.
Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.
The Journal of Pediatrics|September 20, 2001
Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell DiseaseS T Miller, E A Macklin, C H Pegelow, et al.
Blood|November 1, 2011
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessDavide Rossi, Alessio Bruscaggin, Valeria Spina, et al.
Blood|February 7, 2012
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemiaDavide Rossi, Marco Fangazio, Silvia Rasi, et al.
Blood|December 7, 2006
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter studyRiccardo Bomben, Michele Dal Bo, Daniela Capello, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Blood|March 1, 2007
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemiaValerio Fulci, Sabina Chiaretti, Marina Goldoni, et al.
Hematological Oncology|August 21, 2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphomaIrene Della Starza, Lucia Anna De Novi, Marzia Cavalli, et al.
Iscience|July 8, 2020
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast CancerAmedeo Amedei, Fatemeh Asadzadeh, Francesco Papi, et al.
Pageof 83